The role of toxins in Clostridium difficile infection pathogenesis
毒素在艰难梭菌感染发病机制中的作用
基本信息
- 批准号:10516088
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-10-01 至 2023-09-30
- 项目状态:已结题
- 来源:
- 关键词:ADP Ribose TransferasesADP ribosylationActinsAdherenceAffinityAlpacaAnaerobic BacteriaAntibiotic TherapyAntibioticsAntigensBindingBiological AssayBone MarrowCaringCell physiologyCellsClinicalClostridiumClostridium difficileColonComplexCryoelectron MicroscopyCytoskeletonDendritic CellsDiarrheaDiseaseElementsEndocytosisEndosomesEnzymesEpithelial CellsEpitheliumEpitopesFamilyFlow CytometryFoundationsG ActinGenetic TranscriptionGoalsImmunizeIncidenceInfectionInflammasomeIntoxicationKnowledgeLeftLibrariesLifeLipolysisLipoprotein ReceptorMediatingMicrotubulesModelingMorbidity - disease rateMusMutagenesisMutateMutationNF-kappa BNosocomial InfectionsPathogenesisPathologyPerforationPhage DisplayPolysaccharidesPrevalenceProcessProteinsPseudomembranous ColitisReagentRecurrenceRelapseReproduction sporesRoleSepsisSeveritiesSourceStructureSymptomsTLR2 geneTestingToxic MegacolonToxinTransferaseUnited StatesVDAC1 geneVaccine AntigenVeteransVeterans Health AdministrationVirulence Factorseosinophilhost microbiomemilitary veteranmortalitymutantnanobodiesreceptorresponsesynergismtooltreatment strategyvaccine developmentvaccine trial
项目摘要
Project Summary
Clostridioides difficile is a gram-positive, spore-forming anaerobe, a leading cause of nosocomial
infection in the United States, and a significant problem for Veterans receiving care in Veterans Health
Administration (VHA) facilities. The disease state is most often preceded by disruption of the host microbiome in
response to antibiotic treatment and is characterized by mild to severe (and often recurrent) diarrhea. Left
untreated, C. difficile infection (CDI) can be life threatening with sequelae that include antibiotic-associated
pseudomembranous colitis, toxic megacolon, and sepsis.
CDI is dependent on the secretion of one or more AB-type toxins: toxin A (TcdA), toxin B (TcdB), and the
C. difficile transferase toxin (CDT, or binary toxin). While TcdA and TcdB are considered the primary virulence
factors, multiple studies suggest that CDT increases the severity of CDI. The increasing prevalence of CDT
containing clinical isolates and the potential for developing CDT as an effective vaccine antigen necessitate a
deeper understanding of the CDT mechanism of action.
CDT belongs to the Iota family of binary toxins and consists of two proteins: an ADP-ribosyltransferase
(CdtA) and a cell binding and pore-forming protein (CdtB). CdtB engages host cells by binding the lipolysis
stimulated lipoprotein receptor (LSR). Proteolytic cleavage promotes CdtB oligomerization into a prepore which
allows for CdtA binding. The CdtA-CdtB prepore complex is internalized by endocytosis, and endosome
acidification leads to CdtB pore formation and CdtA translocation into the cell. CdtA-mediated disruption of actin
cytoskeletal structure has been associated with the formation of microtubule protrusions that could play a role in
C. difficile adherence to the epithelium. CDT can also synergize with TcdA/TcdB to promote inflammasome
activation and suppression of an otherwise protective eosinophil response.
We have obtained structures of the CdtB prepore and CdtB pore by cryo-electron microscopy. We
propose to define the structures of CdtB bound to CdtA and the LSR receptor (Aim 1), and to dissect the
structural features involved in epithelial cell intoxication (Aim 1) and inflammasome priming (Aim 2) using
structure-guided mutagenesis and functional studies. In parallel, we will generate a panel of CdtB specific
nanobodies that can be used to define the important epitopes needed for high affinity binding and neutralization
(Aim 3). The over-arching goal is to provide the mechanistic foundation for understanding the role of CDT
function in pathogenesis and the tools to advance this knowledge into effective vaccine development strategies.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dana Borden Lacy其他文献
Dana Borden Lacy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dana Borden Lacy', 18)}}的其他基金
Vanderbilt Antibody and Antigen Discovery for Clostridioides difficile Vaccines
艰难梭菌疫苗的范德比尔特抗体和抗原发现
- 批准号:
10625686 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Project 1: Mucosal toxin subunit immunization as a strategy for C. difficile vaccine development
项目 1:粘膜毒素亚基免疫作为艰难梭菌疫苗开发的策略
- 批准号:
10625692 - 财政年份:2023
- 资助金额:
-- - 项目类别:
12th International Conference on the Molecular Biology and Pathogenesis of Clostridia (Clostpath 12)
第十二届梭状芽胞杆菌分子生物学和发病机制国际会议 (Clostridia 12)
- 批准号:
10318438 - 财政年份:2021
- 资助金额:
-- - 项目类别:
The role of toxins in Clostridium difficile infection pathogenesis
毒素在艰难梭菌感染发病机制中的作用
- 批准号:
10412917 - 财政年份:2015
- 资助金额:
-- - 项目类别:
Pre-clinical evaluation of Clostridium difficile toxin inhibitors
艰难梭菌毒素抑制剂的临床前评价
- 批准号:
9487905 - 财政年份:2015
- 资助金额:
-- - 项目类别:
The role of toxins in Clostridium difficile infection pathogenesis
毒素在艰难梭菌感染发病机制中的作用
- 批准号:
9889242 - 财政年份:2015
- 资助金额:
-- - 项目类别:
Structural mechanisms of Clostridium difficile pathogenesis
艰难梭菌发病机制的结构机制
- 批准号:
9212765 - 财政年份:2011
- 资助金额:
-- - 项目类别:
Structural Mechanisms of Clostridioides difficile pathogenesis
艰难梭菌发病机制的结构机制
- 批准号:
10620653 - 财政年份:2011
- 资助金额:
-- - 项目类别:
Structural mechanisms of Clostridium difficile pathogenesis
艰难梭菌发病机制的结构机制
- 批准号:
9916698 - 财政年份:2011
- 资助金额:
-- - 项目类别:
相似海外基金
Control of genomic integrity and virulence of Aspergillus fumigatus by ADP-ribosylation.
通过 ADP-核糖基化控制烟曲霉的基因组完整性和毒力。
- 批准号:
MR/X007472/1 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Fellowship
Understanding the impact of DNA ADP-ribosylation on telomere function in cancer cells
了解 DNA ADP-核糖基化对癌细胞端粒功能的影响
- 批准号:
10751121 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Composition and function of telomeric multi-protein complexes and their regulation by ADP-ribosylation
端粒多蛋白复合物的组成和功能及其ADP-核糖基化的调节
- 批准号:
2748032 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Studentship
A Chemical Footprinting Approach towards Poly-ADP-Ribosylation-regulated Biomolecular Condensation
聚 ADP 核糖基化调节生物分子缩合的化学足迹方法
- 批准号:
10524783 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Regulation of DNA repair by histone ADP-ribosylation
组蛋白 ADP 核糖基化调节 DNA 修复
- 批准号:
MR/W017350/1 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Research Grant
Regulation and function of site-specific protein poly-ADP-ribosylation
位点特异性蛋白质聚 ADP 核糖基化的调控和功能
- 批准号:
10668492 - 财政年份:2022
- 资助金额:
-- - 项目类别:
ADP-ribosylation of DNA in Mycobacterium tuberculosis
结核分枝杆菌 DNA 的 ADP-核糖基化
- 批准号:
BB/W016613/1 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Research Grant
A Chemical Footprinting Approach towards Poly-ADP-Ribosylation-regulated Biomolecular Condensation
聚 ADP 核糖基化调节生物分子缩合的化学足迹方法
- 批准号:
10610165 - 财政年份:2022
- 资助金额:
-- - 项目类别:
A Chemical Footprinting Approach towards Poly-ADP-Ribosylation-regulated Biomolecular Condensation
聚 ADP 核糖基化调节生物分子缩合的化学足迹方法
- 批准号:
10389853 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Role of Transcription Factor ADP-ribosylation in Breast Cancer Biology
转录因子 ADP-核糖基化在乳腺癌生物学中的作用
- 批准号:
10593900 - 财政年份:2021
- 资助金额:
-- - 项目类别: